Bassam Janji
机构: Luxembourg Institute of Health
每年引用次数
引用次数
引用: 22,692
H-指数: 50
I10-指数 : 76
出版物: 148
The beta-carboline Harmine sensitives microsatellite stable colorectal cancer mouse model to anti-PD-1 through upregulating MHC-I dependent antigen presentation machinery and improving the infiltration of CD8 T cells into the tumor microenvironment
Ruize Gao , Kris Van Moer , Coralie Pulido , Anaïs Oudin
Cancer Research 84 ( 6_Supplement) 4049 -4049
2024
Exploring the impact of methylglyoxal stress on tumor immunity
Victoria Mohring , Pascale Hubert , Marie Ancion , Marie-Julie Nokin
Séminaire Télévie 2024
2024
Methylglyoxal stress: a novel role in tumor immunity?
Victoria Mohring , Pascale Hubert , Marie Ancion , Marie-Julie Nokin
Annual Meeting of the Belgian Association for Cancer Research (BACR)
2023
Enhancement of anti-tumor immunity through interference with glycation stress in breast cancer
Victoria Mohring , Pascale Hubert , Marie Ancion , Marie-Julie Nokin
GIGA day
2023
Methylglyoxal reshapes breast tumor immune microenvironment
Victoria Mohring , Tom Wissocq , Pascale Hubert , Michael Herfs
European association for cancer research congress 2022
2022
Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Yosra Messai , Muhammad Zaeem Noman , Meriem Hasmim , Bassam Janji
Cancer research 82 ( 8) 1671 -1671
2022
Immunosuppressive effect of methylglyoxal stress in breast cancer
Victoria Mohring , Tom Wissocq , Pascale Hubert , Michael Herfs
Annual meeting of the Belgian Association for Cancer Research
2022
Methylglyoxal regulates the recruitment of tumor-infiltrating immunosuppressive cells in breast cancer
Victoria Mohring , Tom Wissocq , Pascale Hubert , Michael Herfs
PhD Day UNamur 2022
2022
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy (vol 6, eaax7881, 2020)
Muhammad Zaeem Noman , Santiago Parpal , Kris Van Moer , Malina Xiao
SCIENCE ADVANCES 7 ( 15)
2021
Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape
Tom Wissocq , Pascale Hubert , Assia Tiamiou , Meriem Hasmim
4th METABOLISM & CANCER SYMPOSIUM VIRTUAL MEETING
2021
The link between drug resistance in Multiple Myeloma and Hypoxia
Nassera Aouali , Manon Bosseler , Vanessa Marani , Guy Berchem
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38 S40 -S40
2016
Role of ITPR1/HIF-2α axis in protecting renal cancer cells against natural killer cells.
Yosra Messai , Zaeem Noman , Meriem Hasmim , Bassam Janji
Journal of Clinical Oncology 33 ( 7_suppl) 417 -417
2015
Stress hypoxique et immunoévasion tumorale: Implication des cellules" Natural Killers" et des microvésicules tumorales
Guy Berchem , Bassam Janji , Zaeem Noman
Éditions universitaires européennes
2015
Hypoxia: A Formidable Saboteur of the Anti-tumor Response
Meriem Hasmim , Yosra Messai , Stéphane Terry , Bassam Janji
Resistance of Cancer Cells to CTL-Mediated Immunotherapy 115 -142
2015
Hypoxia-induced autophagy and TNF-alpha resistance in breast cancer cells leads to tumor evasion from NK-mediated immunosurveillance by downregulation of ICAM1.
Bassam Janji , Joanna Baginska , Sandrine Medves , Kris Van Moer
Cancer Research 73 ( 8_Supplement) 4994 -4994
2013
Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.
I Akalay , T Z Tan , P Kumar , B Janji
Oncogene 34 ( 17) 2261 -2271
43
2015
Hypoxia: A Key Feature of the Tumor Microenvironment Triggers Several Mechanisms of Evasion from Natural Killer and Cytotoxic T Lymphocytes Surveillance
T Mgrditchian , T Arakelian , J Paggetti , E Viry
J Immun Res 1 ( 2) 8 -8
1
2014
Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer. Cancers 2021, 13, 1165
M Xiao , M Hasmim , A Lequeux , KV Moer
s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affil-iations.
2021
2308P CyPep-1 reprograms the tumor microenvironment and enhances the efficacy of immune checkpoint inhibitors
B Janji , M Zaeem Noman , J Hossain , L Prestegarden
Annals of Oncology 34 S1180 -S1180
2023
Ucha nski
A Chevigné , B Janji , M Meyrath , N Reynders
Blood 119 5250 -5260
5
2012